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Medical technologies usually are associated with diagnostic or therapeutic devices or
procedures. The association tends toward the "high-tech" side of the developmental
spectrum and emphasizes the recent transfer of experimental techniques to the bed-
side. Preventive health care technologies are usually not considered to be in the main-
stream of technology assessment. This may in part be because, despite the academic
acceptance of the U.S. Office of Technology Assessment's definition of health care
technology as the "drugs, devices, and medical and surgical procedures used in med-
ical care, and the organizational and supportive systems within which such care is
provided," the more general use of technology tends to connote a mechanical or elec-
trical piece of equipment. Another factor that may emphasize the assessment of diag-
nostic and curative technologies over preventive ones is the linkage of technology as-
sessment with reimbursement for medical expenses, health care cost containment, and
quality control. These issues are central to clinical technologies but remain tangential
to most preventive technologies.
This state of affairs can be illustrated by a cursory review of subjects in the issues
of the last 3 years of this journal. Of over 90 articles, 2 could be considered as dealing
with a preventive technology. We seek to fill in some of this gap with this issue, in
which we focus exclusively on preventive technologies. We hope to demonstrate for
the reader that (a) these are vitally important aspects of our efforts to improve health;
(b) these preventive technologies not only merit assessment, they require it; and (c)
the methodologies for, and issues of, technology assessment have several key differ-
ences for preventive versus clinical subjects.
The range of preventive technologies is broad and can be classified along a con-
tinuum of degree of "preventability." At one end is our ability to actually prevent an
adverse health event from occurring (primary prevention). If we cannot prevent ill-
ness, we then aim at its early detection (secondary prevention), with the understanding
that detection at a pathological process's earliest stages is more likely to lead to cure
or reversal of the process. Finally, when we either do not have the tools for early detec-
tion or such detection does not alter the course of illness, we can take steps to prevent
the complications of disease (tertiary prevention).
When carried to an extreme, such as the use of heroic measures in an intensive
care unit to "prevent" death, the use of "prevention" is disingenuous. The preventive
medicine purist is most comfortable with primary prevention activities, but will em-
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brace some secondary prevention activities (such as screening) if the outcomes seem
substantial. One factor that seems to make technologies of tertiary prevention more
acceptable is if they permit an individual to avoid an increased degree of disability.
For example, we do not have the knowledge or tools for preventing juvenile-onset
(insulin-dependent) diabetes. Likewise, we have no data that prove that early detection
and management affects this disease's outcomes. But we do know that proper manage-
ment by both patient and health care provider, while a patient is still fully or mostly
functional, will avert or appreciably delay sequelae such as lower extremity amputa-
tion and visual impairment.
The articles comprising this issue present assessments of a variety of preventive
technologies. For the category of primary prevention, which may be thought of as
synonymous with health promotion, we have chosen to look at two broad-based ap-
proaches. The first, school health education, deals with a multiplicity of risk factors
for many diseases and hazards. Provided to young people during the crucial period
of their physical and intellectual growth, this prevention technology, potentially one
of the most powerful, conveys knowledge of bodily functions and of their relationship
to healthy and unhealthy behaviors. During this period, a young person's health can
be profoundly influenced by decisions involving such lifestyle-forming behaviors as
eating habits; physical activity; and use of tobacco, alcohol, and other addictive sub-
stances. The knowledge provided through school health education, along with tech-
niques designed to encourage positive health attitudes and behaviors, has been shown
to be effective in a number of studies using different curricula. Dwyer et al. review
the progress and effectiveness of school health education programs.
Another broad primary prevention approach involves community interventions.
For over two decades around the world, many of these community-based efforts have
focused on cardiovascular disease and the several risk factors for coronary heart dis-
ease that have been documented. Vartiainen et al. review population-based programs
designed to alter blood cholesterol and lipoproteins.
The annual U.S. Public Health Service Surgeon General's Report on Smoking pro-
vides a useful background document for assessment of smoking prevention and con-
trol strategies, and there is a growing literature on behavioral, epidemiologic, economic,
legal, social, and other aspects of smoking. For this issue, Mackay and Davis assess
community approaches to reducing smoking in populations.
Immunization is a primary preventive technology that has received considerable
assessment. For this issue, Steffen et al. focus on a particular use of immunizations
in the setting of relief and refugee missions. Hatziandreu et al. examine the cost-
effectiveness of hepatitis-B vaccination in Greece. This article provides an example
of a cost assessment of a relatively new vaccine and explores the issue of how disease
prevalence contributes to technology assessment and, consequently, to decision making.
One of the great triumphs of modern preventive medicine, and indeed of medicine
in general, has been the dramatic decline in dental caries through the fluoridation of
water. In this issue, Corbin evaluates fluoridation and other oral disease preventive
technologies used on a community basis.
There are many opportunities for preventive approaches in environmental and oc-
cupational health. Actions that can prevent disease and hazards include altering in-
dustrial design, enacting laws, using safety equipment, and teaching workers safe prac-
tices. The study of motor vehicle collisions, a particular environmental hazard, provides
a rich example of the wide assortment of preventive technologies that can contribute
to the control of this problem. For this issue, Chorba systematically assesses technolo-
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gies developed and designed to prevent motor vehicle collisions or to reduce death
and injury when collisions occur.
Early detection of disease using a variety of screening tools is a widespread form
of primary and secondary prevention. The screening may be targeted to risk factors
(blood tests for cholesterol, community blood pressure measurement for hypertension),
to early stages of disease (mammography for breast cancer, Pap smears for cervical
dysplasia and carcinoma in situ), or to congenital abnormalities (amniocentesis for
specific birth defects, school-based screening for scoliosis). In this issue, Rosenbrock
considers screening for HIV infection and offers a controversial view of this practice.
La Vecchia et al. review the effectiveness of screening for various types of cancer.
This issue does not attempt to provide an exhaustive review of preventive tech-
nology. Many important disease prevention and health promotion technologies are
not reviewed here, such as dietary interventions, exercise programs, prenatal screening,
and multiphasic chemistry screening. Those that are presented, however, provide rich
illustrations of the varieties and importance of preventive technologies and their need
for assessment.
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